Gender | Group A (n = 21) | Group B (n = 21) | Test | p | ||
---|---|---|---|---|---|---|
No. | % | No. | % | |||
 • Male | 14 | 66.7 | 13 | 61.9 | χ2= 0.104 | 0.747 |
 • Female | 7 | 33.3 | 8 | 38.1 | ||
Age (years) | Group A (n = 21) | Group B (n = 21) |  | |||
 • Min.– Max. | 0.83–14.0 | 3.67–14.0 | t =  1.206 | 0.235 | ||
 • Mean ± SD. | 10.21 ± 3.39 | 9.0 ± 3.09 | ||||
PVR risk factors | Group A (n = 21) | Group B (n = 21) |  | |||
No. | % | No. | % | χ2 | p | |
 • Multiple breaks | 5 | 23.8 | 3 | 16.7 | 0.303 | FEp=0.702 |
 • Large or GRT | 10 | 47.6 | 4 | 22.2 | 2.717 | 0.099 |
 • Vitreous hemorrhage | 5 | 23.8 | 5 | 27.8 | 0.080 | FEp=1.000 |
 • Choroidal hemorrhage | 4 | 19.0 | 1 | 5.6 | 1.579 | FEp=0.349 |
 • Extensive RD | 18 | 85.7 | 14 | 77.8 | 0.415 | FEp=0.682 |
Duration of RD (months) | Group A (n = 16) | Group B (n = 16) | U | p | ||
 • Min.– Max. | 0.50–7.0 | 0.25–5.0 | 101.5 | 0.323 | ||
 • Mean ± SD. | 2.56 ± 1.96 | 1.85 ± 1.36 | ||||
Duration of surgery (min.) | Group A (n = 21) | Group B (n = 21) | U | p | ||
 • Min.– Max. | 30.0–90.0 | 30.0–80.0 | 176.0 | 0.260 | ||
 • Mean ± SD. | 64.05 ± 18.68 | 57.14 ± 18.0 |